SearchDictionaryMobileLogin

Osteoarticular Tuberculosis

312  relevant articles (1 outcomes, 14 trials/studies) found for this Disease

Description: Tuberculosis of the bones or joints.

Also Known As:
Tuberculosis, Osteoarticular; Bone Tuberculoses; Joint Tuberculoses; Osteoarticular Tuberculoses; Tuberculoses, Bone; Tuberculoses, Joint; Tuberculoses, Osteoarticular; Tuberculosis, Bone; Tuberculosis, Joint; Bone Tuberculosis; Joint Tuberculosis

Relationship Network

Disease Context: Research Results

Related Diseases

1. Tuberculosis
2. Pulmonary Tuberculosis (Phthisis)
3. Meningeal Tuberculosis (Tuberculous Meningitis)
4. Lymphatic Diseases (Lymphadenopathy)
5. Infection

Experts

1. van Hellemondt, G G: 1 article (08/2008)
2. Vreeling, A W J: 1 article (08/2008)
3. de Haan, J: 1 article (08/2008)
4. Kumar, S: 1 article (03/2003)
5. Harinath, B C: 1 article (03/2003)
6. Banerjee, S: 1 article (03/2003)
7. Strzalkowski, J: 1 article (11/2002)
8. Filewska, M: 1 article (11/2002)
9. Demkow, U: 1 article (11/2002)
10. Nowak-Misiak, M: 1 article (11/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Osteoarticular Tuberculosis:
1. Isoniazid (Ftivazide)FDA LinkGeneric
2. IproniazidIBA
3. Streptomycin (Streptomycin Sulfate)FDA Link
4. Rifampin (Rifampicin)FDA LinkGeneric
5. AntibodiesIBA
6. p-Aminosalicylic Acid (PAS)FDA Link
7. AntigensIBA
8. Thioacetazone (Thiacetazone)IBA
9. Antitubercular AgentsIBA
10. Immunoglobulin G (IgG)IBA
04/01/2003 - "In abdominal and bone & joint tuberculosis cases, ES-41 antigen showed better sensitivity of 81.5% (22/27) and 84.6% (22/26) respectively in IgG antibody detection compared to 70% (19/27) and 69.2% (18/26) shown by ES-31"
06/01/2001 - "In histopathologically proven bone and joint tuberculosis and abdominal tuberculosis cases EST-DE1 antigen showed better sensitivity of 75% and 83.3% respectively in IgG antibody detection compared to that of ESAS-7 antigen (50% and 66% respectively)"
04/01/2003 - "This study is of interest that different antigen protein fractions of M.tb exhibit differential seroreactivity, as ES-31 protein showed good potential in detecting tuberculous IgG antibodies in tuberculous lymphadenopathy (TBLN) & tuberculous meningitis (TBM), while ES-41 in abdominal and bone & joint tuberculosis cases."
03/01/2000 - "Fifty patients of bone and joint tuberculosis (age 15-70 years) and 30 healthy controls were studied for levels of immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), T cells and circulating immune complexes (CICs) in different stages of disease"
06/01/2001 - "Two different excretory-secretory antigenic proteins of M.tbH37Ra viz., EST-DE1 (a 6% TCA soluble and DEAE anion exchange purified antigen) and ESAS-7 (50% ammonium sulphate solubilized and SDS-PAGE fractionated antigen) were studied in stick-indirect penicillinase ELISA for detecting tuberculous IgG antibodies in serum samples of pulmonary as well as extrapulmonary tuberculosis (tuberculous lymphadenopathy (TBLN), tuberculous meningitis (TBM), bone & joint tuberculosis (B&J TB), abdominal tuberculosis (Abd"
Order ALL the reference details at left...

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Anesthesia
3. Arthroplasty
4. Heliotherapy
5. Prostheses and Implants (Prosthesis)

Best Treatments:
Research Summary Report
on Osteoarticular Tuberculosis
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>